Prevalence and burden of epilepsy in Nigeria: A systematic review and meta-analysis of community-based door-to-door surveys

Owolabi, Lukman; Owolabi, Shakirah Desola; Taura, Aminu Abdullahi; Alhaji, I.; Ogunniyi, A

doi:10.1016/j.yebeh.2018.12.017

Cited by 25 publications

(16 citation statements)

References 33 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The published national lifetime prevalence of any mental disorder in Nigeria is approximately 12% (although experts have estimated this to be 20–30% in actuality) [ 5 ], with some regional studies indicating even higher numbers [ 6 – 8 ]. The prevalence of neurological disorders vary by condition, but epilepsy, for instance, has been estimated at 8 per 1000 people [ 9 ]. Substance-use disorders have been estimated between 20 and 40% among youths and 14% in the general population [ 10 ].…”

Section: Introductionmentioning

confidence: 99%

Integrating mental health into primary care: evaluation of the Health Action for Psychiatric Problems In Nigeria including Epilepsy and SubstanceS (HAPPINESS) pilot project

Chu¹,

Roxas

Aguocha

et al. 2022

BMC Health Serv Res

View full text Add to dashboard Cite

Background The Health Action for Psychiatric Problems In Nigeria including Epilepsy and SubstanceS (HAPPINESS) project trains non-specialist and primary health care workers in Imo State, Nigeria. This project adapted the World Health Organization’s Mental Health Gap Action Programme-Intervention Guide (mhGAP-IG), emphasizing stigma reduction among trainees. This convergent mixed-methods proof-of-concept study evaluates the HAPPINESS pilot project mhGAP-IG training’s impact on mental illness stigma among trainees and barriers, facilitators, and opportunities to consider for project improvement. Methods Trainees (n = 13) completed a 43-item questionnaire before and after their 5-day training to assess perceptions of mental disorders and attitudes towards people with mental illness. These responses were analyzed using paired-sample t-tests for four subscales of the questionnaire: acceptance of socializing with people with mental illness, normalizing activities and relationships with people with mental illness, supernatural causation of mental illness, and endorsement of a biopsychosocial approach to mental illness. Semi-structured key informant interviews (n = 11) with trainees, trainers, and local health officials who participated in or supported the HAPPINESS project were thematically analyzed to understand their experiences and perspectives of the project’s barriers, facilitators, and opportunities. Results Trainees showed significant improvements on socializing, normalizing, and supernatural causation subscales of the stigma questionnaire (p < 0.05). No significant effect was seen on the biopsychosocial subscale; however, evidence of biopsychosocial beliefs was found in interview responses. Key informant interviews revealed that the HAPPINESS project enhanced trainees’ diagnostic and treatment abilities, mental health awareness, and empathy towards patients. Misinformation, stigma, inadequate funding, and lack of road access to clinics were identified as barriers to mental health care integration into general care in Imo State. Respondents also suggested ways that the HAPPINESS project could be improved and expanded in the future. Conclusions This study adds to the limited evidence on the implementation of mhGAP-IG in Nigeria. Using mixed methods, it evaluates how mhGAP-IG can impact perceptions and knowledge of stigma among primary care trainees. It also highlights barriers, facilitators, and opportunities to consider for project growth. Future efforts should focus on clinical support, supervision, health outcomes, as well as scaling up and assessing the cost-effectiveness of the HAPPINESS project intervention.

show abstract

Section: Introductionmentioning

confidence: 99%

Integrating mental health into primary care: evaluation of the Health Action for Psychiatric Problems In Nigeria including Epilepsy and SubstanceS (HAPPINESS) pilot project

Chu¹,

Roxas

Aguocha

et al. 2022

BMC Health Serv Res

View full text Add to dashboard Cite

show abstract

“…Среди проанализированных исследований в Нигерии распространенность эпилепсии колебалась от 0,53% (5,3 на 1000) до 3,7% (37 на 1000). Стратифицированный анализ сельских и городских районов показал, что распространенность эпилепсии в городских условиях составила 0,6%, a в сельских районах составила 1,5% [10].…”

Section: результатыunclassified

Epidemiological features of epilepsy in the countries of the African continent

Ефремов

Dolgusheva

Ndihokubvayo

2020

jour

View full text Add to dashboard Cite

This review is devoted to the analysis of the published results of studies conducted in Africa, which studied the clinical and epidemiological features of epilepsy disease in the countries of the African continent. Continental geographic subregions have been identified where the prevalence of epilepsy is particularly high. The relationship between the incidence of epilepsy and the presence of endemic neuroinfections is described. It is concluded that the strengthening of measures aimed at the prevention of infections of the central nervous system can be one of the most effective ways to reduce the morbidity and mortality from epilepsy in Africa

show abstract

“…With Nigeria's estimated population of 217 million, a meta-analysis on the burden of epilepsy in Nigeria put the overall prevalence rate at 8 per 1000 people. 7,8 A large percentage of this population has no access to treatment options, with AEDs not readily available in some regions. Despite advances in ES programs in developed countries, Nigeria currently has no ES program.…”

Section: Introductionmentioning

confidence: 99%

Epilepsy surgery in Nigeria: the current state and prospects

Yakubu¹,

Morakinyo²,

Ghazal³

et al. 2022

Int Surg J

View full text Add to dashboard Cite

Epilepsy, a common neurologic disease, has puzzled mankind since ancient times. The disease has been attributed to different scientific, metaphysical, and spiritual causes and as such many interesting treatment modalities have been used in its management. The course of the modern-day management of epilepsy mirrors the advances in understanding of medicine and neuroscience over time, as well as technological advancements of the past century. Although anti-epileptic drugs (AEDs) are widely used as the mainstay of treatment, some forms of epilepsy are pharmaco-resistant. To tackle these pharmaco-resistant or anatomically complex forms of epilepsy, many neuroscientists, neurologists and neurosurgeons have researched, developed, and refined several successful surgical approaches for the treatment of epilepsy over the past century. These surgeries have revolutionized care for patients with drug resistant epilepsy ensuring seizure control or complete seizure freedom and are widely used in developed countries. Unfortunately, access to epilepsy surgery (ES) is little or non-existent in countries of the global south, often due to varying combinations of financial and infrastructural constraints as well as knowledge and skill gaps among healthcare professionals, and cultural and religious beliefs among the populace. In Nigeria particularly, ES is in the nascent stage and efforts to improve access to ES through local research and international collaborations for capacity building and system strengthening are currently underway.

show abstract

Prevalence and burden of epilepsy in Nigeria: A systematic review and meta-analysis of community-based door-to-door surveys

Cited by 25 publications

References 33 publications

Integrating mental health into primary care: evaluation of the Health Action for Psychiatric Problems In Nigeria including Epilepsy and SubstanceS (HAPPINESS) pilot project

Integrating mental health into primary care: evaluation of the Health Action for Psychiatric Problems In Nigeria including Epilepsy and SubstanceS (HAPPINESS) pilot project

Epidemiological features of epilepsy in the countries of the African continent

Epilepsy surgery in Nigeria: the current state and prospects

Contact Info

Product

Resources

About